Digital Access

Digital Access
Access theherald-news.com from all your digital devices and receive breaking news and updates from around the area.

Home Delivery

Home Delivery
Local news, sports, business, classified and more! News you can use every day.

Text Alerts

Text Alerts
Choose your news! Select the text alerts you want to receive: breaking news, weather, and more.

Email Newsletters

Email Newsletters
Have our latest news, sports and obituaries emailed directly to you Monday through Friday so you can keep up with what's happening in the area.
Local Business

AATD commonly misdiagnosed as chronic asthma

SPONSORED

Antitrypsin Deficiency, known as AATD, is an inherited condition passed from parents to their children through their genes.

The deficiency will result in serious lung disease in adults and, at times, can also cause lung disease in young adults.

AATD is commonly misdiagnosed as chronic asthma or COPD. In fact, out of the 12 million patients diagnosed with COPD in America, approximately 1 to 3 percent likely have A1AD.

Left untreated, A1AD results in progressive destruction of lung tissue resulting in severe loss of lung function and life expectancy.

Laird Ozmon of Ozmon Law in Joliet has pioneered the fight to seek fair compensation for those patients who have been misdiagnosed and have suffered such serious lung damage.

AATD cannot be diagnosed by symptoms or by a medical examination alone; you need to get a simple, reliable blood test to know for sure.

When AATD relates to the lungs, individuals experience shortness of breath – especially at rest, wheezing, chronic bronchitis, reoccurring chest colds, year-round allergies or early onset of emphysema.

When AATD relates to the liver, individuals experience unexplained liver disease or elevated liver enzymes. They may have jaundice or swelling of the abdomen or legs.

Required treatment involves serum replacement of this protein, which then provides this protective coating. However, lost lung function cannot be restored and most misdiagnosed patients ultimately must undergo lung transplants to extend life expectancy.

Laird Ozmon has a proven track record of obtaining high dollar value settlements and jury verdicts involving personal injury law and Alpha-1 Antitrypsin Deficiency (AATD) cases, including one of the first and highest settlements for an Alpha-1 patient for $8 Million dollars.

While Ozmon Law is handling your case, Laird will always try to negotiate a fair settlement on your behalf. However, if a fair settlement cannot be negotiated, Laird’s 30 years of trial experience will work for you in attempting to recover maximum compensation from the jury.

Ozmon Law : 54 North Ottawa St., Joliet, IL 60432 : 815-727-7700 : www.ozmonlaw.com